Pragma Bio is a biotech company that uses proprietary methods in genomic sequencing, artificial intelligence, and synthetic biology to discover biomarkers for immunologic disorders. They have developed a first-of-its-kind-map of chemicals designed by nature, housed in humans, and linked to immune-related health outcomes. They are utilizing patient data to explore the synergistic bond between nature’s chemistry found in the human body and the immune system with the goal of discovering novel medicines.
However, they have recently secured $10 million in equity to continue their development of proprietary methods in drug discovery.
Location: United States, California, South San Francisco
Employees: 11-50
Total raised: $10M
Founded date: 2019
Investors 5
Date | Name | Website |
17.08.2023 | Good AI Ca... | goodai.cap... |
14.04.2023 | Harmonix | harmonixfu... |
22.04.2023 | Iaso Ventu... | iasoventur... |
- | StartX | startx.com |
- | Bioverge | ventures.b... |
Funding Rounds 1
Date | Series | Amount | Investors |
27.03.2023 | - | $10M | The Ventur... |
Mentions in press and media 4
Date | Title | Description | Source |
27.03.2023 | California-based startup Pragma Bio raises USD 10 million in... | California’s – Pragma Bio, the tech-enabled platform for drug discovery previously known as VastBiom... | vcbay.news... |
25.03.2023 | Pragma Bio Secures $10M in Equity Funding | Pragma Bio, a South San Francisco, CA-based technology-enabled platform for drug discovery, raised $... | finsmes.co... |
23.03.2023 | Pragma Bio is searching for cancer treatments hidden in our ... | The natural world has produced many of our most important medicines, but instead of looking under a ... | techcrunch... |
23.03.2023 | Pragma Bio Receives $10M Financing Round | SOUTH SAN FRANCISCO, CA, Pragma Bio, the technology-enabled platform for drug discovery formerly k... | vcnewsdail... |